Current problems in the care of patients with inflammatory bowel disease in the Czech Republic

nflammatory bowel disease poses a significant health, social and economic problem. A modern advanced therapy of IBD is effective and safe, and, simultaneously, reduces patients‘ disability together with indirect costs. The access to advanced therapy in Czech Republic is, however, a half of what we need in the real clinical practice. To improve this, we have to analyze both direct and indirect costs, increase budgets for advanced therapy and improve communication between the key stakeholders within the health and social system. Keywords ulcerative colitis, inflammatory bowel disease, Crohn’s disease, direct cost, indirect costs, invalidity